IDiyas

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Zhulun Wang

LinkedIn
USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 9.0

ph-index = 7

Forward Citations = 177(Granted Patents)


Location History:

  • Foster City, CA (US) (2006 - 2009)
  • Thousand Oaks, CA (US) (2022 - 2023)
  • Palo Alto, CA (US) (2012 - 2024)
  • Los Altos, CA (US) (2024)

Company Filing History:

goldMedal23 out of 1,970 
 
Amgen Inc.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):
1. 12435149 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2025-10-07),
2. 12252540 - Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) (2025-03-18),
3. 11965029 - ST2 antigen binding proteins (2024-04-23),
4. 11891435 - Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof (2024-02-06),
5. 11739131 - Growth differentiation factor 15 (GDF-15) polypeptides (2023-08-29),
6. 11541103 - Interleukin-21 mutein/ anti-PD-1 antibody conjugates (2023-01-03),
7. 11518808 - Anti-PD-1 antibodies and methods of treatment (2022-12-06),
8. 11248043 - Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof (2022-02-15),
9. 11059895 - ST2 antigen binding proteins (2021-07-13),
10. 11046774 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2021-06-29),
11. 10894814 - Growth differentiation factor 15 (GDF-15) constructs (2021-01-19),
12. 10738110 - PAC1 antibodies and uses thereof (2020-08-11),
13. 10465009 - BCMA antigen binding proteins (2019-11-05),
14. 10336798 - Growth differentiation factor 15 (GDF-15) polypeptides (2019-07-02),
15. 10294303 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2019-05-21),

Title: The Innovative Journey of Zhulun Wang

Introduction: Zhulun Wang, a visionary inventor based in Palo Alto, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Wang's latest patents include a revolutionary AI-powered healthcare device designed to improve patient monitoring and a cutting-edge renewable energy system that enhances sustainability in urban environments.

Career Highlights: With a background in electrical engineering, Wang has a successful track record of developing innovative solutions. He has worked for leading tech companies, where he spearheaded projects that have received international recognition for their impact on society.

Collaborations: Wang has collaborated with top research institutions and universities to further his inventions. His partnerships have led to the development of advanced technologies that have the potential to shape the future of various industries.

Conclusion: Zhulun Wang's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…